Medscape: German Society Updates Rheumatic Diseases Guidelines in Light of SARS-CoV-2 Pandemic
UC rheumatologist discusses new guidance for treating rheumatic disease during COVID-19
Avis Ware, MD, director and professor in the UC Division of Allergy, Immunology and Rheumatology, spoke with Reuters Health for a story about the German Society for Rheumatology updating its guidelines to reflect the impact of the COVID-19 pandemic. A key change is a recommendation that anti-rheumatic medication should not be changed solely for fear of SARS-CoV-2 infection.
Other key findings include that patients with an inflammatory rheumatic disease (IRD) do not have a higher risk of contracting SARS-CoV-2 and that IRD patients should follow the same behavioral and precautionary measures as the general population. Ware told Reuters Health that many of the recommendations overlap with guidance from the American College of Rheumatology and the European League Against Rheumatism.
Read the full interview in Medscape online.
Learn more about Avis Ware, MD.
Featured image of Avis Ware, MD, taken by Colleen Kelley/UC Creative + Brand.
Related Stories
Ancient Maya blessed their ballcourts
April 26, 2024
Using environmental DNA analysis, researchers identified a collection of plants used in ceremonial rituals in the ancient Maya city of Yaxnohcah. The plants, known for their religious associations and medicinal properties, were discovered beneath a plaza floor upon which a ballcourt was built, suggesting the building might have been blessed or consecrated during construction.
OTR mural centerpiece of 'big' celebration of UC alumni
April 26, 2024
New downtown artwork salutes 18 alumni award recipients who personify UC’s alumni success.
2024 Daniel Drake Medals to be awarded April 27
April 24, 2024
The UC College of Medicine will award three people with 2024 Daniel Drake Medals April 27.